chemistry-cs-2020

Clinical Genomics

The "Clinical Genomics" track at our esteemed conference. This track serves as a focal point for professionals dedicated to harnessing the power of genomics to revolutionize clinical practice, offering insights into the latest advancements, translational research, and clinical applications in the field of genomics.

Key topics covered in the Clinical Genomics track include:

1. Genomic Technologies and Platforms: Explore the diverse array of genomic technologies and platforms, including next-generation sequencing (NGS), microarray analysis, and single-cell sequencing, and their applications in genomic profiling, variant detection, and functional genomics studies.

2. Clinical Interpretation of Genomic Data: Navigate through the complexities of interpreting genomic data, including variant annotation, pathogenicity assessment, and genotype-phenotype correlations, and discuss strategies for integrating genomic information into clinical decision-making.

3. Cancer Genomics and Precision Oncology: Investigate the role of genomics in cancer biology, including somatic mutations, driver genes, and tumor heterogeneity, and explore the applications of precision oncology approaches, such as targeted therapies, immunotherapy, and liquid biopsies, in personalized cancer care.

4. Rare and Mendelian Disorders: Address the challenges of diagnosing and managing rare and Mendelian disorders through genomic sequencing approaches, including whole-exome sequencing (WES) and whole-genome sequencing (WGS), and discuss the implications for genetic counseling, family screening, and therapeutic interventions.

5. Pharmacogenomics and Personalized Medicine: Explore the intersection of genomics and pharmacology in personalized medicine, including the identification of genetic variants influencing drug response and metabolism, and discuss the implications for drug selection, dosing optimization, and adverse drug reaction prediction.

6. Genomic Epidemiology and Population Health: Examine the applications of genomics in epidemiological studies, population health research, and disease surveillance, including genome-wide association studies (GWAS) and polygenic risk scoring, and discuss their implications for public health interventions and precision public health initiatives.